Kineticos Ventures

Kineticos Invests in Significant, Unmet Medical Needs in Oncology, Neurosciences and Rare Diseases

Kineticos invests in Seed, and Series A and B rounds of life science companies with differentiated platform technologies. While financial resources are essential for the growth of emerging technologies, Kineticos provides in-depth industry knowledge, relationships, a community of advisors, and thoughtful execution to portfolio companies

Kineticos focuses on significant, unmet medical needs in oncology, neurosciences, and rare diseases and invests in entrepreneur scientists working on platform technologies to address large, unmet medical needs. Within our focus areas, Kineticos has invested in contract services, enabling technology, diagnostics, and biotechnology companies.

Kineticos has invested in cell and gene therapy therapeutics and believes there may be significant future growth in the contract services and enabling market.